Koichi Kameda

The Introduction of Nucleic Acid Tests (NAT) for Blood Screening in the Brazilian Public Healthcare System: Negotiating and Assembling Technologies for the Nationalization of ‘NAT Brasileiro’ (2005–2013)

Koichi Kameda, 2018, Health Innovation and Social Justice in Brazil.

Testing COVID-19 in Brazil: fragmented efforts and challenges to expand diagnostic capacity at the Brazilian Unified National Health System.

I. Löwy, Maurice Cassier, R. Caetano, 2021, Cadernos de saude publica.

Imperfect diagnosis: The truncated legacies of Zika testing

I. Löwy, J. Lezaun, A. Kelly, 2021, Social studies of science.

Innovation in diagnostics: addressing gaps in low- and middle-income countries

C. Chamas, M. Corrêa, Koichi Kameda, 2022, Bulletin of the World Health Organization.

Needs-driven versus market-driven pharmaceutical innovation: the consortium for the development of a new medicine against malaria in Brazil.

Koichi Kameda, 2014, Developing world bioethics.